Ashley works from a technical perspective and has contributed to the translation of hyperpolarised 13C-MRI for use in humans, including the operation of the clinical hyperpolariser and the establishment of a dedicated pharmacy facility to produce consumables for its use. Alongside this, Ashley focuses on supporting innovative molecular imaging methods to study key biological processes in tumours, with the aim of translating these advances into clinical practice.
